2301085-04-9
2301085-04-9
Chemical Structure
Emzadirib
Synonym(s): CYT-0851; RAD51-IN-2
- CAS No.: 2301085-04-9
- Formula:C27H40N4O6S2
- Molecular Weight:580.76
IUPAC Name: isopropyl ((1r,4r)-4-(5-(2-(N-(tert-butyl)sulfamoyl)-4-((isopropoxycarbonyl)amino)phenyl)thiazol-2-yl)cyclohexyl)carbamate
InChIKey: OVXFEICGTUUFPE-WGSAOQKQSA-N
SMILES: CC(OC(N[C@H]1CC[C@H](C2=NC=C(C3=CC=C(NC(OC(C)C)=O)C=C3S(=O)(NC(C)(C)C)=O)S2)CC1)=O)C
Biological Activity: Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Emzadirib | 99.32% | Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emzadirib (Standard) | ≥98% | Emzadirib (Standard) is the analytical standard of Emzadirib (HY-111887). This product is intended for research and analytical applications. Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
